Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026)
Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Voyager Therapeutics |
222.52 Mn |
81.04 Mn |
- |
-115,976.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-115,976.00 |
| Dec 31, 2025 |
-170,156.00 |
| Sep 30, 2025 |
-25,043.00 |
| Jun 30, 2025 |
203,909.00 |
| Mar 31, 2025 |
276,329.00 |
| Dec 31, 2024 |
-55,608.00 |
| Sep 30, 2024 |
165,205.00 |
| Jun 30, 2024 |
206,877.00 |
| Mar 31, 2024 |
33,529.00 |
| Dec 31, 2023 |
42,525.00 |
| Sep 30, 2023 |
-63,886.00 |
| Jun 30, 2023 |
-42,191.00 |
| Mar 31, 2023 |
21,272.00 |
| Dec 31, 2022 |
156,171.00 |
| Sep 30, 2022 |
11,634.00 |
| Jun 30, 2022 |
-270,496.00 |
| Mar 31, 2022 |
-271,717.00 |
| Dec 31, 2021 |
114,008.00 |
| Sep 30, 2021 |
-71,969.00 |
| Jun 30, 2021 |
-111,106.00 |
